Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents.

Source:http://linkedlifedata.com/resource/pubmed/id/9443618

Download in:

View as

General Info

PMID
9443618